arrow
F

Fabrice Bonnet

Universite de Bordeaux
H指数:62
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reinforced strategies versus standard pneumococcal vaccination regimen in patients with ANCA-associated vasculitides receiving rituximab therapy: A Multicenter Randomized Controlled Trial

利妥昔单抗治疗的患者中,强化策略与标准肺炎球菌疫苗接种方案的比较:一项多中心随机对照试验

2026-01-010
OA
Quality of Life and Treatment Satisfaction in People with HIV Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide: Pooled Analysis from Observational Cohort Studies

生活质量及治疗满意度:接受Bictegravir/Emtricitabine/Tenofovir Alafenamide转换治疗的HIV感染者——基于观察性队列研究的合并分析

2025-11-240
OAAI
Projecting changes in demographics and causes of death in people with HIV in western Europe from 2025 to 2050: a mathematical modelling study

预测2025年至2050年西欧地区HIV感染者人口结构和死亡原因的变化:一项数学建模研究

2025-11-070
OAAI
Testosterone therapy is associated with reduced risk of acute kidney injury, kidney failure with renal replacement therapy, and cardiovascular events in men with diabetes and hypogonadism

睾酮疗法与糖尿病伴性腺功能减退男性的急性肾损伤、需行肾脏替代治疗的肾衰竭以及心血管事件风险降低相关。

2025-10-030
OA
Care interruptions and mortality among adults in Europe and North America
AIDS
IF3.1
2024-05-142
OA
SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe
2023-05-2979
OAAI
What are the factors associated with long-term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second-line therapy? Results from the DISCOVER study
2021-08-026
PREAI
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe

SCORE2风险预测算法: 估计欧洲10年心血管疾病风险的新模型

2021-06-13689
OA
Type 2 diabetes and heart failure: insights from the global DISCOVER study

2型糖尿病和心力衰竭: 来自全球DISCOVER研究的见解

2021-02-1111
OA